Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.7/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already mark it as read-only, non-destructive, idempotent, and open-world. The description adds specific behavioral details: for companies it pulls latest 10-K financials with correct fiscal-year handling (e.g., AAPL Sep, NVDA Jan), and for drugs it pulls FAERS, FDA, and trial counts. Results are sorted by primary metric. No contradiction with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with trigger phrases and efficiently packs information. It's slightly dense but not verbose. Every sentence adds value, though it could be slightly more streamlined without losing clarity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given two parameters and no output schema, the description fully explains input, behavior, and output (paired data + pipeworx:// citation URIs). It also notes efficiency (replaces 8–15 sequential lookups) and sorting behavior, making it self-contained.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% with clear descriptions. The description further enriches parameter meaning: explains how 'type' determines data source (SEC EDGAR vs. FAERS) and how 'values' accept tickers/CIKs or drug names. Examples like '["AAPL","MSFT"]' and '["ozempic","mounjaro"]' clarify usage.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description starts with trigger phrases like 'Compare X and Y' and clearly states it performs 'side-by-side comparison of 2–5 companies or drugs in ONE parallel call.' It distinguishes the tool from sequential single-entity lookups (e.g., entity_profile) by emphasizing parallel batch processing.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly states 'ALWAYS PREFER over sequential single-pack lookups when comparing entities,' giving clear when-to-use guidance. It also provides example queries and specifies entity types (company/drug) with concrete data sources.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Most of the surface is dominated by overlapping meta-tools (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research) plus paired helpers (discover_tools/suggest_questions, ai_visibility_check/scan_competitor_ai_presence), so an agent can easily pick the wrong one. The seven treasury_* tools are clearly distinct, but they are a small island in a much larger ambiguous set.

Naming Consistency3/5

Names are broadly snake_case and family-prefixed (treasury_*, polymarket_*, pipeworx_*), which helps, but the pattern is not consistently verb_noun: ask_pipeworx, bet_research, entity_profile, deep_research, search_within, and recent_changes mix verb, noun, and product-specific naming styles. Within families it is readable, but across the whole set it is inconsistent.

Tool Count2/5

37 tools is too many for a server whose label is 'Treasury Fiscal'; only about six tools are treasury-specific and the rest are unrelated research, betting, memory, and subscription utilities. This is well into the 25+ heavy range and would make tool selection expensive and error-prone.

Completeness2/5

For a Treasury/Fiscal server the surface is thin: debt, receipts, customs duty, average rates, exchange rates, and net cost cover only a slice of Treasury data. Missing obvious components such as daily yield curves, auction calendars/results, federal outlays/spending by agency or function, and tax or appropriations data; the broad ask_pipeworx router softens but does not fill these as first-class tools.